Efficacy and safety of extended-release oral opioid for cough in idiopathic pulmonary fibrosis: A systematic review and meta-analysis of randomized controlled trials.
Sarcoidosis vasculitis and diffuse lung diseases · 30.09.2026 · 43 (3) · 18930-18930
DOI: 10.36141/svdld.2026.18930 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Sarcoidosis vasculitis and diffuse lung diseases, erschienen am 30.09.2026. Verfasst von Shun Nakahara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND AND AIM: Patients with idiopathic pulmonary fibrosis (IPF) experience a high burden of cough. Currently, no established effective therapy exists for cough in IPF. The overall evidence base of oral extended-release (ER) opioid therapies in this population remains limited. This study aimed to compare the efficacy and safety of ER oral opioids versus placebo for cough in patients with IPF. METHODS: PubMed, Embase, Cochrane, and ClinicalTrial.gov databases were reviewed for randomized controlled trials (RCTs). The primary outcome was 24-hour objective cough frequency. Secondary outcomes included Evaluating Respiratory Symptoms-Idiopathic Pulmonary Fibrosis (E-RS IPF) cough subscale score, Cough Severity-Numeric Rating Scale (CS-NRS) score. Safety outcomes included serious adverse events and adverse events leading to discontinuation. RESULTS: Three RCTs, including 250 patients, were analyzed. Opioid interventions included ER nalbuphine and morphine. ER opioid statistically significantly improved 24-hour objective cough frequency (GMR 0.46; 95% CI 0.23 to 0.92; p = 0.029), CS-NRS score (MD -1.69; 95% CI -2.55 to -0.84; p < 0.001), and E-RS IPF cough subscale score (MD -0.49; 95% CI -0.89 to -0.09; p = 0.016), compared with placebo. No statistically significant differences were observed for serious adverse events or adverse events leading to discontinuation. CONCLUSIONS: ER oral opioids significantly improved cough frequency and patient-reported cough severity and discomfort in patients with IPF, without a significant increase in serious adverse events or treatment discontinuation. Extended-release opioids may be cautiously considered as a therapeutic option for cough in patients with IPF.
Schlagwörter
Autor:innen und Institutionen
- Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI.
- Intensive Care Unit, National Western Medical Center, Mexican Social Security Institute, Guadalajara, Jalisco, Mexico; Department of Medical Clinics, University Center for Health Sciences and University Center of Tlajo…
- Federal University of Santa Catarina Medical School, Santa Catarina, Brazil.
- Pulmonary and Critical Care Division, Queen's University Medical Group, Honolulu, HI, USA.
ORCID-Profile: Shun Nakahara, Ana Alicia Velarde-Pineda, Maria Júlia Moura
Zitieren
APA
Nakahara, S., Velarde-Pineda, A. A., Moura, M. J., & Matsuda, B. (2026). Efficacy and safety of extended-release oral opioid for cough in idiopathic pulmonary fibrosis: A systematic review and meta-analysis of randomized controlled trials. Sarcoidosis vasculitis and diffuse lung diseases, 43(3), 18930-18930. https://doi.org/10.36141/svdld.2026.18930
Vancouver
Nakahara S, Velarde-Pineda AA, Moura MJ, Matsuda B. Efficacy and safety of extended-release oral opioid for cough in idiopathic pulmonary fibrosis: A systematic review and meta-analysis of randomized controlled trials. Sarcoidosis vasculitis and diffuse lung diseases. 2026;43(3):18930-18930. doi:10.36141/svdld.2026.18930
BibTeX
@article{Nakahara2026,
author = {Nakahara, Shun and Velarde-Pineda, Ana Alicia and Moura, Maria Júlia and Matsuda, Brent},
title = {Efficacy and safety of extended-release oral opioid for cough in idiopathic pulmonary fibrosis: A systematic review and meta-analysis of randomized controlled trials},
journal = {Sarcoidosis vasculitis and diffuse lung diseases},
year = {2026},
volume = {43},
number = {3},
pages = {18930--18930},
doi = {10.36141/svdld.2026.18930}
}
EUVIMED